FindTrial
Sign In

Comparison of 2 drug combinations in hand surgeries in anesthesia

Comparison of nalbuphine and butorphanol as an adjuvant to levobupovacaine in ultrasound guided supraclavicular brachial plexus block : a randomized comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035931
Enrollment
80
Registered
2021-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Levobupivacaine plus butorphanol: 25 ml 0.5% Levobupivacaine as a local anesthetic agent used along with opioid analgesic 1mg butorphanol in supraclavicular brachail plexus block Contro

Sponsors

Rohilkhand medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.American society of Anesthesiologist (ASA) grade I or II 2. Age between 18-60 years 3. Either sex 4. Posted for upper limb surgery under ultrasound guided supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria: 1.Patients refusal for the procedure 2. Patients receiving anticoagulants, β- blockers or opioids, psychotropic drugs. 3. Patients with history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease. 4. Patients with history of alcohol or drug abuse. 5. Patients with hypersensitivity or contraindication to Levobupivacaine, Nalbuphine and Butorphanol. 6. Pregnant or lactating women. 7. Patients on chronic analgesic therapy, diabetes or coagulation disorders. 8. Patients with local skin site infection

Design outcomes

Primary

MeasureTime frame
Upto 24 hoursTimepoint: Prolonged analgesia—

Secondary

MeasureTime frame
Enhance recoveryTimepoint: On day one—

Countries

India

Contacts

Public ContactUpasana Asooja

Bareilly international university

dr_malti_agrawal@yahoo.com8899626464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026